Newest first
New topics page 14
Topics ordered by when they were created rather than by activity. This is where a question that nobody has answered yet is easiest to find — and answering one is the fastest route to a first solution badge.
1,535 topics · page 14 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Follow-up: How to disagree with an answer you were given, well
How to disagree with an answer you were given, well I have a specific reason for asking rather than idle curiosity, and the context is below. Question in the title and the context underneath, in the order the…
|
2 | 16k | 30d | |
|
CJC-1295 with and without DAC: what the modification does
On the subject in the title: CJC-1295 with and without DAC: what the modification does Working notes rather than a conclusion. Putting the numbers in the first post, because a question about a compound…
|
+117 | 123 | 5.6k | 22h |
|
Follow-up: Patterns that reliably precede a problem, documented
On the subject in the title: Patterns that reliably precede a problem, documented Working notes rather than a conclusion. A follow-up question about Patterns that I did not know to ask the first time. The…
|
2 | 70 | 1d | |
|
Preservatives: function, testing, and limits — one year on
On the subject in the title: Preservatives: function, testing, and limits — one year on Working notes rather than a conclusion. Asking about Preservatives directly, because I have read four threads on it and…
|
+28 | 32 | 437 | 8d |
|
A widely repeated interaction claim that turns out to be unsupported — what changed since
A widely repeated interaction claim that turns out to be unsupported — what changed since Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about widely repeated…
|
+89 | 94 | 5.9k | 2h |
|
Coming back to: Light exposure: how much protection is proportionate?
Asking directly, because I could not find a straight answer: Light exposure: how much protection is proportionate? Reading back through what has been written here about Light exposure, three questions come up…
|
+5 | 10 | 13k | 2d |
|
Preprint servers and what screening they do — the long version
On the subject in the title: Preprint servers and what screening they do — the long version Working notes rather than a conclusion. A preprint question rather than a question about the finding in it. The…
|
+7 | 11 | 26k | 4mo |
|
When a dose reduction is the correct response to a side effect
When a dose reduction is the correct response to a side effect — that is the question, and I have not found it answered plainly anywhere I have looked. I have read the maintained page on this and I still have…
|
+38 | 42 | 2.7k | 19h |
|
Revisiting: Maintainer handover: how it works
Revisiting: Maintainer handover: how it works Writing it up because I had to work it out twice and would rather nobody else did. Maintainer handover keeps being re-asked here and I think that is because the…
|
+53 | 57 | 664 | 4mo |
|
Why "dose equivalence" between different incretin analogues is a weak concept
Why "dose equivalence" between different incretin analogues is a weak concept I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on this…
|
+124 | 133 | 11k | 5mo |
|
Prescription portability between countries — the long version
On the subject in the title: Prescription portability between countries — the long version Working notes rather than a conclusion. A narrow question about Prescription portability between countries,…
|
2 | 182 | 21h | |
|
[2026 update] Regional warehouse stock versus direct despatch
Regional warehouse stock versus direct despatch Writing it up because I had to work it out twice and would rather nobody else did. Working notes on Regional warehouse stock versus direct rather than a…
|
+135 | 147 | 32k | 2d |
|
What other technical communities get right that we do not
What other technical communities get right that we do not — that is the question, and I have not found it answered plainly anywhere I have looked. A digression I have been saving for the right category. It is…
|
+2 | 6 | 23k | 5h |
|
Why this subcategory is stricter about sourcing than most
Asking directly, because I could not find a straight answer: Why this subcategory is stricter about sourcing than most A comparison question rather than a question about one compound. Two things in the same…
|
+48 | 52 | 617 | 21d |
|
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on
Asking directly, because I could not find a straight answer: Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Posting the method first, because I know what the first three…
|
+10 | 14 | 13k | 5mo |
|
The headache that turns out to be dehydration — the long version
On the subject in the title: The headache that turns out to be dehydration — the long version Working notes rather than a conclusion. A narrow question about headache, deliberately narrow, because the broad…
|
+68 | 73 | 1.3k | 12h |
|
About the Special populations category
Older adults, pregnancy and pregnancy planning, adolescents, renal and hepatic impairment, bariatric surgery history. This post is a community wiki: any member at trust level 3 or above can edit it, and every…
|
4 | 3k | 4mo | |
|
Resolution and tailing factor: real acceptance criteria
Resolution and tailing factor: real acceptance criteria Writing it up because I had to work it out twice and would rather nobody else did. Asking about resolution and tailing factor on behalf of the question…
|
2 | 15k | 1mo | |
|
Journal club: orforglipron phase 2 and the non-peptide question
Journal club: orforglipron phase 2 and the non-peptide question Writing it up because I had to work it out twice and would rather nobody else did. Orforglipron phase 2, and specifically the version of it that…
|
+120 | 132 | 13k | 1d |
|
Coming back to: Time to steady state after a dose increase
Time to steady state after a dose increase Writing it up because I had to work it out twice and would rather nobody else did. Working through the kinetics rather than the pharmacology, because I think the…
|
+104 | 110 | 16k | 2d |
|
Coming back to: Why I now write the concentration on the vial in marker
The question in the title: Why I now write the concentration on the vial in marker I will give what I have already checked below so nobody repeats it. Writing this out with the numbers in it, because…
|
+8 | 12 | 4.3k | 1d |
|
About the Doc review category
Review of drafts and revisions before and after promotion. Every promotion is discussed in public. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded…
|
4 | 25k | 4mo | |
|
Mass error in ppm: the arithmetic and the caveat
Mass error in ppm: the arithmetic and the caveat Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like it checked.…
|
+108 | 125 | 1.5k | 5mo |
|
[2026 update] Composite endpoints and the component doing the work
On the subject in the title: Composite endpoints and the component doing the work Working notes rather than a conclusion. Comparing SURMOUNT-1 ( N Engl J Med , 2022) with SURPASS-4 ( Lancet , 2021) and…
|
+76 | 87 | 994 | 3mo |
|
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still hold?
Asking directly, because I could not find a straight answer: What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still hold? An honest uncertainty about TRIUMPH rather than a…
|
+43 | 47 | 5.5k | just now |
|
Nausea profile of amylin analogues compared with GLP-1 agonists
Nausea profile of amylin analogues compared with GLP-1 agonists Writing it up because I had to work it out twice and would rather nobody else did. I have spent a fortnight trying to pin nausea profile of…
|
+70 | 76 | 3k | 4mo |
|
Second pass at: Identical chromatograms across two different lots
Posting this under the heading it deserves: Second pass at: Identical chromatograms across two different lots Everything below is what sits behind that. Something about Identical chromatograms does not…
|
+81 | 93 | 13k | 4mo |
|
About the HPLC & UHPLC category
Reversed-phase separations, gradients, columns, integration, and reading a chromatogram properly. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded…
|
4 | 137 | 18h | |
|
Type 2 diabetes and the largest part of the evidence base
Posting this under the heading it deserves: Type 2 diabetes and the largest part of the evidence base Everything below is what sits behind that. Trying to work out what would count as evidence on type 2…
|
+81 | 89 | 2.9k | 3mo |
|
A genuinely late dose: what the labelling says and what people do
On the subject in the title: A genuinely late dose: what the labelling says and what people do Working notes rather than a conclusion. A methods question rather than a substantive one, about genuinely late…
|
2 | 18k | 5mo |